Equillium (EQ) Cash from Financing Activities (2018 - 2026)

Equillium's (EQ) quarterly Cash from Financing Activities came in at $35.3 million in Q1 2026, up 38741.76% year-on-year from N/an in Q1 2025, and up 12389.75% on a QoQ basis from $283000.0 in Q4 2025.

Equillium (EQ) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Equillium (EQ) has 9 years of Cash from Financing Activities data on file, last reported at $35.3 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 38741.76% year-over-year to $35.3 million in Q1 2026; TTM through Mar 2026 was $65.7 million, a 26929.63% increase from a year earlier, with the FY2025 full-year figure at $30.4 million, up 18453.05% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $35.3 million, up from $283000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for EQ reached as high as $35.3 million in Q1 2026 and fell as low as -$7.6 million in Q2 2023.
  • Historically, Cash from Financing Activities has averaged $5.0 million across 5 years, with a median of $73000.0 in 2024.
  • Across the five-year window, Cash from Financing Activities tumbled 702.67% in 2022 and surged 38741.76% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$1.4 million in 2022, then soared by 105.83% to $79000.0 in 2023, then retreated by 7.59% to $73000.0 in 2024, then jumped by 287.67% to $283000.0 in 2025, then surged by 12389.75% to $35.3 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $35.3 million in Q1 2026, $283000.0 in Q4 2025, and $30.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Equillium 258.99 Mn 258.99 Mn - 35.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.35 Mn
Mar 31, 2026 35.35 Mn
Dec 31, 2025 283,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 30.07 Mn
Sep 30, 2025 30.07 Mn
Jun 30, 2025 -16,000.00
Jun 30, 2025 -16,000.00
Mar 31, 2025 91,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 73,000.00
Dec 31, 2024 73,000.00
Dec 31, 2023 79,000.00
Dec 31, 2023 79,000.00
Sep 30, 2023 -260,000.00
Sep 30, 2023 -260,000.00
Jun 30, 2023 -7.62 Mn
Jun 30, 2023 -7.62 Mn
Mar 31, 2023 -1.43 Mn
Mar 31, 2023 -1.43 Mn